跳至主要内容
临床试验/NCT00794053
NCT00794053已完成3 期

The Role of Sentinel Lymph Node Biopsy (SLNB) In the Management of Differentiated Thyroid Cancer

University of Alexandria1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2002年12月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
45
试验地点
1
主要终点
The lymph nodes around the thyroid tumour will be removed and examined under microscopy in all study subjects to verify that the stained node is a true representative to the state of lymph nodes as regards tumour spread

研究概览

简要总结

Detection of lymph nodes starting to be involved by cancer spreading from the thyroid gland during operation is useful. It saves the patient from having a second operation to remove these nodes later on when they become obvious. The problem is that there are many lymph nodes around the gland. The theory is that only one node will get the first spill of the tumour cells.

In this study the investigators are trying to use an inert colored material to inject into the tumour. This should run in the same path as the tumour cells and should therefore stain the one lymph node that will be affected first should the tumour spread.

The stained lymph node is excised and examined instantaneously for tumour affection. If it is found to be affected by the tumour, then the operation is extended to include removal of all its fellow lymph nodes. If it is found to be free from the tumour, then this patient does not have tumour spread.

详细描述

The study includes 45 consecutive patients diagnosed as differentiated thyroid cancer by clinical examination and/or fine needle aspiration cytology (FNAC).

Exclusion criteria are: previous neck surgery, pregnancy and known hypersensitivity to the dye used.

An informed consent was obtained from all the patients. Peroperative workup includes history taking, clinical examination, relevant laboratory investigations including thyroid hormone assay, ultrasonography of the neck with special emphasis on the thyroid focal lesion and cervical lymph nodes. FNAC was attempted in all patients.

All patients were then subjected to operation:

A systematized surgical approach was adopted for the purpose of the study: this started by collar incision, development of sub-platysmal skin flaps and separation of strap muscles in the midline. This was followed by exposure of the thyroid gland; identification of the thyroid tumour; injection of the dye into the tumour; waiting for the dye to reach the lymph nodes; identifying the stained node; labeling it as the sentinel node (SLN); performing total thyroidectomy and bilateral central neck dissection.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Patient diagnosed to have differentiated thyroid carcinoma and has no detectable cervical lymphadenopathy.

排除标准

  • •Previous neck surgery, pregnancy and known hypersensitivity to the dye used.

研究组 & 干预措施

study group

Experimental

The members in this group will undergo intervention by having surgery and lymph node detection by dye staining

干预措施: detecting lymph node metastasis by staining (Procedure)

结局指标

主要结局

The lymph nodes around the thyroid tumour will be removed and examined under microscopy in all study subjects to verify that the stained node is a true representative to the state of lymph nodes as regards tumour spread

时间窗: the lymph nodes removed during the surgery will be examined the next day of the operation

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
Identification of lymphatic metastasis in patients with thyroid cancer by means of sentinel lymph node biopsy using [68Ga]Ga-tilmanocept PET/CTThe IMP will be used for the identification of sentinel lymph nodes in patients with thyroid carcinomaMedDRA version: 21.1Level: PTClassification code 10066474Term: Thyroid cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10072873Term: Sentinel lymph node mappingSystem Organ Class: 100000004848MedDRA version: 20.1Level: LLTClassification code 10073554Term: Sentinel node biopsySystem Organ Class: 100000004848
EUCTR2021-002470-42-NLniveristy Medical Center Utrecht10
已完成
3 期
Sentinel lymph node detection in thyroid carcinoma using 68Ga-tilmanocept PET/CT: A proof of concept study10014713thyroid carcinomaThyroid cancer
NL-OMON55234niversitair Medisch Centrum Utrecht10
Unknown
2 期
Extent of Central Lymph Node Dissection in Papillary Thyroid MicrocarcinomaCarcinoma
NCT01149161Samsung Medical Center2,000
进行中(未招募)
不适用
Biopsy ME study - Node biopsy for patients with early stage Merkel Cell Carcinoma,Early stage (cT1N0) Merkel Cell CarcinomaCancer - Non melanoma skin cancer
ACTRN12618000528257South Western Sydney Local Health District29
已完成
1 期
Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CWSurgeryThyroid Carcinoma
NCT06095362University Medical Center Groningen20